Posted in | News | Nanoenergy | Nanoanalysis

Desmet Ballestra Participates in 8th Euro Fed Lipid Congress in Germany

The 8th Euro Fed Lipid Congress was held in Munich, Germany from November 21 – 24, 2010.

The European Federation for the Science and Technology of Lipids congresses are recognized as annual "don't miss this!" event of the Lipids, Fats and Oils world with up to 850 delegates, including 200 students. N.V. Desmet Ballestra Group s.a., a European based conglomerate and worldwide leader in the design and delivery of advanced processing systems for vegetable (edible) oil extraction and refining facilities throughout the world, was participating at this important Congress. Last month, Desmet and CTi entered into an exclusive new global technology license, marketing and collaboration agreement with respect to CTi's proprietary Nano Reactor™ technology.

According to Roman Gordon, CTi's CEO, "We are very pleased that Desmet participated at this year's Euro Fed Lipid Congress in Munich, Germany, as Wim De Greyt and Marc Kellens presented the Nano Neutralization™ process to an international audience." It was an excellent opportunity for us to introduce and promote our unique Nano Neutralization™ process.  Mr. Gordon also stated that efficiency, quality and sustainability are key criteria for our new improved process in edible oil refining.

Source: http://www.ctinanotech.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.